Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF)

Orion Pharma

Status: Completed

Conditions: Asthma; Chronic Obstructive Pulmonary Disease

Treatments: Device: Diskus inhaler; Device: Easyhaler type B; Device: Easyhaler type A

Study type: Interventional

Funder types: Industry

Identifiers

NCT01424137

3106002

Details and patient eligibility

About

The purpose of this study is to characterise inspiratory flow parameters across 2 Easyhaler® (EH) inhaler versions and Diskus® inhaler in patients with asthma (including children, adults, and the elderly) and in patients with chronic obstructive pulmonary disease (COPD).

Enrollment: 227 patients

Sex: All

Ages: 4+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Written informed consent (IC) obtained
• Documented diagnosis of asthma and/or COPD
• Age: 4 years and above

Exclusion criteria

• Any severe chronic respiratory disease other than asthma or COPD
• Acute respiratory infection
• Any medical condition that in the opinion of the investigator would endanger the subject if he/she participates in the study

Trial design

227 participants in 3 patient groups

Easyhaler type A

Other group

Treatment:

Device: Easyhaler type A

Easyhaler type B

Other group

Treatment:

Device: Easyhaler type B

Diskus inhaler

Other group

Treatment:

Device: Diskus inhaler